Cardiometabolic Index is associated with heart failure: a cross-sectional study based on NHANES DOI Creative Commons
Zhu Xiao-ming, Yan Xu, Jie Zhang

и другие.

Frontiers in Medicine, Год журнала: 2024, Номер 11

Опубликована: Дек. 9, 2024

Heart failure is a complex syndrome characterized by impaired cardiac function. Despite improvements in treatment, the prevalence of heart continues to rise. The Cardiometabolic Index (CMI), novel measure combining abdominal obesity and lipid levels, has emerged as potential predictor metabolic risk.

Язык: Английский

Recent advancements in the multifaceted biomedical efficacy of triazole based metal complexes DOI
Aman Kumar,

Seema Devi,

Sanjeev Kumar

и другие.

Coordination Chemistry Reviews, Год журнала: 2025, Номер 536, С. 216675 - 216675

Опубликована: Апрель 10, 2025

Язык: Английский

Процитировано

1

Novel triazole-tethered thiazol-4(5H)-one hybrids as potential therapeutics for obesity and type 2 diabetes: in vitro, in vivo, and in silico evaluations DOI
Walaa I. El-Sofany,

Amani Toumi,

Ismail Daoud

и другие.

Journal of Molecular Structure, Год журнала: 2025, Номер unknown, С. 142577 - 142577

Опубликована: Май 1, 2025

Язык: Английский

Процитировано

0

A Click Chemistry Approach for the Synthesis of Triazole Linked Vanillin Scaffolds as Potent Pharmacophores: Anti-Diabetic, Anti-Inflammatory, Antioxidant, Molecular Docking and ADMET Investigations DOI
Vardhaman Babagond, Kariyappa S. Katagi, Mahesh Akki

и другие.

Polycyclic aromatic compounds, Год журнала: 2025, Номер unknown, С. 1 - 24

Опубликована: Май 26, 2025

Язык: Английский

Процитировано

0

Novel and efficient synthesis of 5-chloro-6-methoxy-3-(2-((1-(aryl)-1H-1,2,3-triazol-4-yl)methoxy)ethyl)benzo[d]isoxazole derivatives as new α-glucosidase inhibitors DOI

Ram Reddy Mudireddy,

Rambabu Gundla,

Chandra Prakash Koraboina

и другие.

Biochemistry and Biophysics Reports, Год журнала: 2025, Номер 43, С. 102074 - 102074

Опубликована: Июнь 5, 2025

Язык: Английский

Процитировано

0

Importance of the CuAAC Reaction in the Synthesis of Platinum Complexes with 1,4-Disubstituted-1H-1,2,3-triazoles: A Review of Their Anticancer Activity DOI Creative Commons
Delia Hernández‐Romero, Sharon Rosete‐Luna, Enrique Méndez-Bolaina

и другие.

Reactions, Год журнала: 2024, Номер 5(4), С. 947 - 983

Опубликована: Ноя. 24, 2024

Despite multiple advances in treatment and prevention, cancer remains one of the leading causes death worldwide. Chemotherapy most effective method for treatment. However, commercial chemotherapeutic drugs have limited efficacy, severe side effects, acquired resistance. Therefore, scientific community has devoted a great effort to designing new, more effective, cheaper drugs. In this sense, copper-catalyzed azide-alkyne cycloaddition reactions (CuAAC) provide 1,4-disubstituted 1H-1,2,3-triazoles high yields without forming by-products. This reaction allows easy, efficient, functional, ordered, rapid, selective, specific joining small molecules, giving rise complex molecules. The CuACC simplifies synthesis processes, accelerating discovery new agents by allowing platinum drugs, slightly altering their structure, or creating molecules with improved properties. work shows importance CuAAC search metallodrugs possible anticancer activity.

Язык: Английский

Процитировано

0

Cardiometabolic Index is associated with heart failure: a cross-sectional study based on NHANES DOI Creative Commons
Zhu Xiao-ming, Yan Xu, Jie Zhang

и другие.

Frontiers in Medicine, Год журнала: 2024, Номер 11

Опубликована: Дек. 9, 2024

Heart failure is a complex syndrome characterized by impaired cardiac function. Despite improvements in treatment, the prevalence of heart continues to rise. The Cardiometabolic Index (CMI), novel measure combining abdominal obesity and lipid levels, has emerged as potential predictor metabolic risk.

Язык: Английский

Процитировано

0